Company Name, Ticker, Suppliers, else..

Medicines Co (NASDAQ: MDCO)

Sector • Healthcare Industry • Major Pharmaceutical Preparations

Industry • Major Pharmaceutical Preparations

Sector • Healthcare

Medicines Co's

Name: Medicines Co Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MDCO Sales vs. its Competitors Q3 2019

Comparing the current results to its competitors, Medicines Co reported Revenue increase in the 3 quarter 2019 by 0 % year on year.
The revenue growth was below Medicines Co's competitors' average revenue growth of 4.95 %, achieved in the same quarter.

• List of MDCO Competitors

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Medicines Co, despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 3.46 %

<< MDCO Stock Performance Comparisons

<< See the full list of MDCO competitors

*Market share is calculated based on total revenue.

MDCO's Stock Performance relative to its Competitors

Publicly Traded Peers of Medicines Co

Zevra Therapeutics Inc
Share Performance

+23.45%

30 Days

Zevra Therapeutics Inc

Profile

Zevra Therapeutics Inc operates on a business model that focuses on the development and commercialization of innovative therapeutics.

More about Zevra Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 707.106 mill.	$ 115.073 mill.	$ 124.218 mill.

Pliant Therapeutics Inc
Share Performance

-3.51%

Over The Past 5 Days

Pliant Therapeutics Inc

Profile

Pliant Therapeutics Inc operates with a business model focused on developing novel therapeutics to address fibrotic diseases. The company conducts extensive research to identify and target specific molecular pathways involved in fibrosis, with the aim of developing effective treatments. Pliant Therapeutics collaborates with academic institutions and conducts preclinical and clinical studies to bring its products to market and improve the lives of patients suffering from fibrotic conditions.

More about Pliant Therapeutics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 67.984 mill.	$ - mill.	$ -113.218 mill.

Pfizer Inc
Share Performance

+13.79%

30 Days

Pfizer Inc

Profile

Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.

More about Pfizer Inc's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 162,193.540 mill.	$ 63,696.000 mill.	$ 4,370.000 mill.

Petvivo Holdings Inc
Share Performance

-13.90%

Over The Past 5 Days

Petvivo Holdings Inc

Profile

PetVivo Holdings Inc's business model revolves around developing and commercializing innovative medical devices that benefit pets.

More about Petvivo Holdings Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 22.270 mill.	$ 1.182 mill.	$ -9.777 mill.

Passage Bio Inc
Share Performance

-62.10%

This Year

Passage Bio Inc

Profile

Passage Bio Inc's business model focuses on developing and commercializing innovative genetic therapies for rare, monogenic central nervous system disorders.

More about Passage Bio Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 14.215 mill.	$ - mill.	$ -36.112 mill.

46 more competitors available

Sources: Medicines Co’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 11:52 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Medicines Co versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.